GoodRx is the leading online platform to access, compare and transact on discounted prescription drug prices

Pharmaceutical manufacturers on the GoodRx platform will now have access to an extensive content library to reach and educate target consumers.

GoodRx was selected out of 60,000 companies and won across all four of this quarter’s categories including Best Company Culture, Best Companies for Women, Best Companies for Diversity, and Best CEOs.

GoodRx has completed its initial public offering on the NASDAQ and raised $900 million in primary proceeds. At the offering price of $33/share, the company is valued at over $14 billion.

GoodRx has once again been recognized on the CNBC Disruptor 50 list for helping Americans find the best prescription drug prices resulting in $20+ billion of savings.